Hypopigmentation from imatinib mesylate (Gleevec)

J Pediatr Hematol Oncol. 2004 Mar;26(3):214. doi: 10.1097/00043426-200403000-00016.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Benzamides
  • Black People*
  • Child
  • Cord Blood Stem Cell Transplantation
  • Humans
  • Hypopigmentation / chemically induced*
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
  • Male
  • Missouri
  • Piperazines / adverse effects*
  • Pyrimidines / adverse effects*

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate